chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I had a reaction; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (I had a reaction) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (I had a reaction). At the time of the report, VACCINATION COMPLICATION (I had a reaction) outcome was unknown. Possible      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported. No treatment related information has been reported.
10 days after varicella vaccine, pt had low grade fever & developed a varicella-like rash, Smaller lesions then wild-type varicella. Positive Pruritus, Involved palms and soles, Symptoms relieved with Tylenol, Calamine Lotion, Generalized erythema papular rash, (?) Mostly on anterior abdomen and back, Some on extremities and microvesicular lesions
Information has been received from a physician and a practice manager via company representative referring to a patient of unknown age and gender. On 09-MAR-2015 the patient was vaccinated with an improperly stored dose of PNEUMOVAX 23-10PK-0.5mlSD-PFS LLokwTip (lot # K019386, expiration date 09-JUN-2016). This specified lot number vaccine was exposed to temperature excursion three times. The total cumulative excursion time was 1172 hours with the highest recorded temperature of -3 Celsius degree. The total cumulative excursion time of the second time was 80 hours with the lowest recorded temperature of 30 Fahrenheit degree. The total cumulative excursion time of the third time was 336 hours with the highest recorded temperature of 59 Fahrenheit degree. The storage criteria and the type of excursion for this vaccine was refrigerator (R). No adverse effect was reported. This is one of several reports received from the same source. Additional information has been requested.
Exertional dyspnea, generalized chest pain, fatigue, difficulty taking deep breaths, depression, anxiety, sleep disturbance, palpitations, chest wall tenderness, orthopnea.
Last night 11/29/12 client began to experience diarrhea, elevated temperature (not taken but mother reports "he felt really hot") and that his "tummy hurt". The symptoms began approximately 6:00 p.m. He was completely recovered by morning. Hospital was called. Hospital staff encouraged to continue to monitor and call if worsens.
Received vaccine on 4/4/01. On 4/5/01, complained of pain, swelling and numbness at right arm (shoulder to just below the injection site). On 4/6/01, symptoms the same.
Patient was given a dose of pediarix, acthib, and prevnar13 that they were not due for. They did not have any adverse reaction at the time the vaccines were given.
Low back muscle pain, leg weakness and low grade temp lasting 48 hours. Emp still continues to have back pain, some leg pain and weakness (staffs incident report 12/16/13).
Recipient reported chest tightness, throat closing up, tachycardia, feeling flush approximately 2 minutes after vaccine administration. B/P- 162/76, HR- 124, O2 sat. 100%.  She was taken to our outpatient clinic for close monitoring. Some symptoms were resolving. She reported right and then left arm numbness with a heavy feeling in her left eye. She remained in the outpatient department for monitoring until approximately 3p last set of vital signs B/P- 109/72, HR- 16, O2 sat. 100%
vaccine received on 4/23/21. Patient stated her arm felt itchy for 3 days. Then on 5/1, she noticed the red spot on the arm along with itchiness and a little swelling.  she is taking loratadine and putting hydrocortisone on the area.
Persistent Left shoulder pain after vaccine. States she thought it was higher up the shoulder than it was supposed to be given. has improved after the first week
pt recv vax 17OCT96 & 22NOV96 exp n/v;seen by MD;no signs of jaundice;seen again 25NOV96 jaundiced, hepatomegaly & elevated liver function tests;found to have hepatitis & placed on bed rest;
Patient accidentally administered Moderna COVID-19 Vaccine Bivalent BUD; No adverse event; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient accidentally administered Moderna COVID-19 Vaccine Bivalent BUD) and NO ADVERSE EVENT (No adverse event) in a 61-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 044H22A) for COVID-19 prophylaxis.     It was unknown if the patient had medical history/conditions, allergy, concomitant diseases and risk factor.   On an unknown date, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient accidentally administered Moderna COVID-19 Vaccine Bivalent BUD) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patient accidentally administered Moderna COVID-19 Vaccine Bivalent BUD) and NO ADVERSE EVENT (No adverse event) outcome was unknown.     For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Patient accidentally administered Moderna COVID-19 Vaccine Bivalent BUD).    No concomitant medications were reported.  The healthcare professional (HCP) mentioned 2 doses were given on 19-Feb-2023, 1 dose on 20-Feb-2023, and 1 dose on 10-Mar-2023. Caller did not specified which date corresponded to patient 1 but HCP stated patient 1 did not reported any AEs.  No treatment medications were reported.  This case was linked to US-MODERNATX, INC.-MOD-2023-715321, US-MODERNATX, INC.-MOD-2023-715348, US-MODERNATX, INC.-MOD-2023-715325 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-715321: US-MODERNATX, INC.-MOD-2023-715348:Patient 1 case US-MODERNATX, INC.-MOD-2023-715325:Patient 1 case
Redness at injection site, itching at injection site, patient self-report of nausea, patient self-report of dizziness, 105 PR, 148/48 BP, 98F. No evidence of difficulty breathing, swelling, or hives.
fever reached to 100.7; chills; headache; muscle pain; nausea; Sore arm; This spontaneous case was reported by a consumer and describes the occurrence of   in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011A21A) for COVID-19 vaccination.     Concurrent medical conditions included Acid reflux (oesophageal), Allergy NOS and Glaucoma. Concomitant products included DEXLANSOPRAZOLE (DEXILANT) for Acid reflux (oesophageal), FEXOFENADINE HYDROCHLORIDE (ALLEGRA) for Allergy, MONTELUKAST SODIUM (SINGULAIR) for Allergy NOS, VALACICLOVIR from an unknown date to 25-Feb-2021 for Antiviral treatment, LATANOPROSTENE BUNOD (VYZULTA) for Glaucoma.    On 26-Feb-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 26-Feb-2021, Body temperature: 100.7 (High) 100.7 fever.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment  information was not provided.
Symptoms are mainly-shooting pains and aching in both of my shoulders and upper arms. Symptoms are constant. Shortly after receiving my 3rd dose of the Lymerix vaccine, I started getting shooting pains and aching in both of my shoulders and both of my upper arms. I went to see the doctor and told him that it all started after receiving the lyme vaccine. Doctor did not know what was causing the pain and aching, so he recommended that I see a doctor at Orthopedic Surgeons. That doctor could not determine what was causing the pain and aching. He thought that it might be bicepetal tendenitious. The pain and aching have not disappeared and they are constant, but sometimes it is more severe than others. I have not had any other treatment since then. Dates that I saw the doctors regarding the pain and aching are on or about 03/08/2000 and 03/22/2000.
STIFF JOINTS, HANDS, JAW.. BY 4/12/2014 COULD NOT WALK, EAT. BECAME PARALYZED FROM THE WAIST DOWN. DIAGNOSED WITH GUILLAIN BARRE SYNDROME AND BRACHIAL NEURITIS. IMMUNE SYSTEM ATTACKED NERVOUS SYSTEM AND ENTIRE BODY, JOINTS, HEART, ETC. SHOULDER (LEFT) DOWN TO ELBOW IS ATROPHIED AND PARALYZED. SPENT 30 DAYS IN HOSPITAL AND 15 DAYS AT AN OT AND PT FACILITY.
Itching head and eyes, rash on neck and arms, tingling of tongue, sore throat, and tachycardia, heart rate 100. did not feel right at all.
Patient experience nausea after receiving vaccine within 20 minutes and had a panic episode after vomiting
Information has been received from a physician assistant concerning a 15 year old female who on 03-DEC-2007 was vaccinated IM in the hip with the first 0.5 mL dose of Gardasil.  On 04-DEC-2007 the patient experienced hip, knee and ankle pain.  Subsequently, the patient recovered from hip, knee and ankle pain.  Additional information has been requested.
Petechiae and bruising noted.  Petechiae on trunk noted in the morning and bruises over bones.
Fever over 101 F, chills, fatigue, muscle pain, nausea, headache, neck pain, sore throat
Pt presented for fatigue, shortness of breath and not feeling well over the weekend. Poor appetite. Pt wears cpap with oxygen at night, using inhalers. patient was found to be covid-19 positive on 11/22/21 patient was admitted for covid-19 infection patient required treatment for symptoms associated with covid-19 with dexamethasone and remdesivir patient was discharged to home on 11/24/21
Severe arm and join pain all over. Chills, and very bad pain in all joins. Can hardly move
Right after the shot I experienced Facial numbness and twitches. I went to the emergency room and they couldn't find an answer of why it was happening. Shortness of breath and chest tightness set in on 08/12/2021. I was told to go back to the ER.
1932: pt stated she felt uneasy, felt heart pounding, gave water and rest, declined BP, manual HR taken, HR: 112 bpm 1933: opened door for fresh air, BP:213/94, HR: 86, no rash or redness at site, does take BP medications daily but forgot today, pt stated she was anxious about coming and had a support person accompany her 1937: BP: 187/96, HR: 83, started to feel better, patient's husband went to car to get clonidine that is prescribed prn for patient, pt did not take at clinic 1940: continue to rest, denied BP retaken, stated heartbeat was normal, she felt good, pt will continue to do V Safe, rested and left at 1942, pt will continue to monitor symptoms and BP at home
pain at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (pain at the injection site) in an 84-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014M20A) for COVID-19 vaccination.     No medical history was provided by the reporter.    On 23-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Feb-2021, the patient experienced VACCINATION SITE PAIN (pain at the injection site). The patient was treated with CLONIDINE at an unspecified dose and frequency. At the time of the report, VACCINATION SITE PAIN (pain at the injection site) outcome was unknown.            Concomitant product use was not provided by the reporter.  Action taken with mRNA-1273 in response to the events was not applicable.
Client received first dose of Moderna Vaccine at 14:57 pm. Sat in observation for 15 mins. 15: 12--Reported to Observer that her right arm felt numb, however received immunization in left arm. 15: 20: APRNs  assessed client and local on-site paramedics notified. Client denied difficulty breathing, or any symptoms typically associated with anaphylaxis.  15:21--BP 148/94, pulse 102 15:26--BP 136/84, pulse 96, O2 saturation @ 99% 15:31--BP 128/97, pulse 94, O2 saturation @ 98% Client able to move arm and vocalized feeling in arm/hands/fingers. EMS offered to take client to ER; client declined transport.  3/18/21 client reports she is feeling well
After receiving the shot I have had headaches every day since receiving the vaccine.  I also sweat more profusely they I did before.  Water just runs off of me.
TOOK TWO DOSES IN A ROW; This spontaneous case (PVX2019-1540) was received from a caregiver on 13-Jun-2019. It describes a 14-year-old adolescent male consumer who "took two doses in a row", while being on oral Vivotif (one capsule every other day) for typhoid prophylaxis.  Case report: The consumer took two doses of Vivotif in a row. The doses were taken on 12-Jun-2019 and 13-Jun-2019, respectively.  Action taken with Vivotif was not applicable.  The clinical outcome of the event was unknown.  Company's Comment: The causality of the event "took two doses in a row" was considered as not applicable.; Sender's Comments: Company's Comment: The causality of the event "took two doses in a row" was considered as not applicable.
sick; This case was reported by a consumer via interactive digital media and described the occurrence of sickness in a male patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 2nd dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced sickness. On an unknown date, the outcome of the sickness was recovered/resolved.   It was unknown if the reporter considered the sickness to be related to Shingles vaccine.     Additional Information: GSK receipt date: 09-FEB-2023 Reporter's comment: This case was reported by a patient via interactive digital media. The reporters husband got second dose of vaccine and had sick for only one day but told to be prepared. Additional Supportive Information: The follow-up could not be possible as no contact details were available.
After receiving the vaccine I was okay until about February of the following year I got a blood clot.
This case was reported by a consumer via call center representative and described the occurrence of adverse drug reaction in a female patient who received SHINGRIX for prophylaxis. On an unknown date, the patient received SHINGRIX at an unknown dose. On an unknown date, unknown after receiving SHINGRIX, the patient experienced adverse drug reaction. On an unknown date, the outcome of the adverse drug reaction was unknown. It was unknown if the reporter considered the adverse drug reaction to be related to SHINGRIX. Additional details were reported as follows: The age at vaccination was not reported. The patient asked that how long to do the side effects last after shingle's shot. The patient was enquiring about taking BENADRYL to help with side effects.
This initial spontaneous report was received from a lawyer regarding a case in litigation and refers to a patient of unknown age and gender. No information was provided regarding concomitant medications, concurrent conditions or medical history. On or about 12-JUN-2012, the patient was vaccinated with a dose of ZOSTAVAX (lot #, expiration date, dose, route and site of administration were not reported) to obtain permanent prevention and protection against shingles and zoster-related injuries. On an unknown date, after and despite being inoculated with the ZOSTAVAX, the patient was diagnosed with shingles and/or other zoster-related injuries and suffered serious physical, emotional and economic damages as a result of patient's injuries. In 2016, the patient was treated for shingles. The reporter considered adverse events to be related to ZOSTAVAX. As a direct and proximate result of the ZOSTAVAX, the patient had and would continue suffer ongoing injuries, including but not limited to: mental and physical pain and suffering; extensive medical care and treatment for these injuries; significant medical and related expenses as a result of these injuries, including but not limited to medical losses and costs including care - for hospitalization, physician care, monitoring, treatment, medications, and supplies; diminished capacity for the enjoyment of life; a diminished quality of life; increased risk of premature death, aggravation of preexisting conditions and activation of latent conditions; lost wages; loss of earnings capacity; and other losses and damages. By the time of the report, the patient did not recover from shingles as the patient suffer for ongoing injuries. The outcome of vaccination failure was unknown. The events were considered to be related to ZOSTAVAX.
Felt Worse; Weird Neurological Sensations; Warm Sensation; Weakness; Tired; Headache; Achiness; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Achiness), FEELING ABNORMAL (Weird Neurological Sensations), FEELING HOT (Warm Sensation), ASTHENIA (Weakness) and FEELING ABNORMAL (Felt Worse) in a 42-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002ZAZ1A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 22-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Feb-2021, the patient experienced PAIN (Achiness), FATIGUE (Tired) and HEADACHE (Headache). On 14-Mar-2021, the patient experienced FEELING ABNORMAL (Weird Neurological Sensations), FEELING HOT (Warm Sensation) and ASTHENIA (Weakness). On 18-Mar-2021, the patient experienced FEELING ABNORMAL (Felt Worse). At the time of the report, PAIN (Achiness), FEELING ABNORMAL (Weird Neurological Sensations), FEELING HOT (Warm Sensation), ASTHENIA (Weakness), FEELING ABNORMAL (Felt Worse), FATIGUE (Tired) and HEADACHE (Headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported.  No treatment information was provided.
Urticaria, Pruritus. Diphenhydramine, sulfamethizole/trimethoprim.
I developed hyperthyroidism in May/June if going by symptoms of hairloss, palpitations, and tachycardia. My labs were checked in early June. I have not had any thyroid issues in the past. I did have COVID in mid October but my thyroid was test at the end of November and was normal. I am currently taken Atenolol and Methimazole.
10 cm local rxn; indurated, warm, reddish, painful; no sign of bleeding;
Tired the same evening, went to bed early. Next morning woke up tired but motivated taking shower and getting ready to work but by 8am was noticing decreased energy and buttocks and backs of legs aching in addition to sore vaccination site. It quickly proceeded to get worse with severe headache, neck pain, arms and legs aching. Throughout the day temperature went up and down and varied from 96 to 102. The highest temperature was the day after vaccination around 6pm about 24-27 hours after. Two days after in the morning, still fatigued and temperature at 97-100 .
came to ED with syncope. tested positive for COVID 2 days prior and given Regeneron 12/1 prior to coming to ED
No additional adverse events reported; administration of PROQU AD to a 19 year old female; This spontaneous report was received from a medical assistant and refers to a 19-year-old female patient. No information regarding the patient's pertinent medical history, drug reactions or allergies and concomitant therapies was provided. On 09-JUN-2021, she was vaccinated at inappropriate age with measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) 0.5 milliliter, recombinant human albumin (rha) (lot # T028296, expiration date 16-FEB-2022) (route of administration was not reported) for prophylaxis. No adverse events were reported.
Patient received second shot on November 14, 2002. About 6 hours later (after shot) patient noticed itchiness in location of vaccination. At about midnight patient noticed his left upper arm was red. Patient noticed today upper arm is swollen, red area is about 7.5in over upper arm. The red area is hot to the touch and sore. Itchy feeling still occurring. Patient state he experienced headaches after this shot and also with the first shot.
Swollen, tender, hot to touch. Left thigh at site of PPV 23 got better with ice pack and 2 doses daily of Clavix and Singulair in 48 hours.
began acting fussy & feverish that noc;came to office 14OCt97 6PM w/a fever of 105.8;no rxn @ site;no appetite on this date;APAP & Advil dosing discusses;returned to be rechecked 16OCT97 temp 97.6;has runny nose & sl cough;
Loss of balance; dizziness; vision problem; Aches in neck; weakness; headache; Chills; Aches in joints; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of BALANCE DISORDER (Loss of balance), DIZZINESS (dizziness), VISUAL IMPAIRMENT (vision problem), NECK PAIN (Aches in neck) and ASTHENIA (weakness) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced BALANCE DISORDER (Loss of balance), DIZZINESS (dizziness), VISUAL IMPAIRMENT (vision problem), NECK PAIN (Aches in neck), ASTHENIA (weakness), HEADACHE (headache), CHILLS (Chills) and ARTHRALGIA (Aches in joints). At the time of the report, BALANCE DISORDER (Loss of balance), DIZZINESS (dizziness), NECK PAIN (Aches in neck), CHILLS (Chills) and ARTHRALGIA (Aches in joints) had resolved and VISUAL IMPAIRMENT (vision problem), ASTHENIA (weakness) and HEADACHE (headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.   Treatment information was not provided.   Most recent FOLLOW-UP information incorporated above includes: On 23-Jul-2021: Follow up received on 23-Jul-2021 contains Significant informations
Patient has been under the services of hospice care since4-7-22. He tested positive COVID positive on 1-23-23 and expired in house 1-30-23